600568 Stock Overview
Engages in the research, development, production, and sales of pharmaceuticals drugs in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 600568 from our risk checks.
Zhongzhu Healthcare Holding Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥1.44 |
| 52 Week High | CN¥1.80 |
| 52 Week Low | CN¥1.13 |
| Beta | 0.33 |
| 11 Month Change | 19.01% |
| 3 Month Change | 10.77% |
| 1 Year Change | -18.64% |
| 33 Year Change | -21.31% |
| 5 Year Change | -15.29% |
| Change since IPO | -49.19% |
Recent News & Updates
Zhongzhu Healthcare Holding Co.,Ltd's (SHSE:600568) Business Is Yet to Catch Up With Its Share Price
Sep 30
Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
May 13Shareholder Returns
| 600568 | CN Real Estate | CN Market | |
|---|---|---|---|
| 7D | -5.9% | -4.4% | -3.4% |
| 1Y | -18.6% | -0.9% | 6.1% |
Return vs Industry: 600568 underperformed the CN Real Estate industry which returned -0.9% over the past year.
Return vs Market: 600568 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 600568 volatility | |
|---|---|
| 600568 Average Weekly Movement | 5.7% |
| Real Estate Industry Average Movement | 8.1% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 600568 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600568's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 1,430 | Bo Anna Wang | www.zz600568.com |
Zhongzhu Healthcare Holding Co.,Ltd engages in the research, development, production, and sales of pharmaceuticals drugs in China. It offers ophthalmology drugs, including pearl eye drops, sodium cromoglycate eye drops solution, acyclovir eye drops, hydroxybenzazole hydrochloride eye drops, acyclovir dispersible tablets, gatifloxacin tablets, etc. It is also involved in production and sales of products, including hepatest ultrasonic liver cirrhosis detector, infusion heater, Luna God full-body gamma knife, etc. In addition, the company engages in residential real estate development, capital market services, technology promotion and application service, medical services and devices, special equipment manufacturing, software and information technology service, hospital investment management, leasing and business services. The company researches and develops drugs, such as Genistein capsule which has completed the phase 2 clinical research for the prevention and treatment of women’s menopausal syndrome, osteoporosis, and anti-tumor effect; Leonurine sulfate tablets, which has completed phase 1b clinical study for the prevention and treatment of cardiovascular and cerebrovascular diseases and strokes; and motherwort.
Zhongzhu Healthcare Holding Co.,Ltd Fundamentals Summary
| 600568 fundamental statistics | |
|---|---|
| Market cap | CN¥2.91b |
| Earnings (TTM) | -CN¥179.65m |
| Revenue (TTM) | CN¥641.61m |
4.5x
P/S Ratio-16.0x
P/E RatioIs 600568 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600568 income statement (TTM) | |
|---|---|
| Revenue | CN¥641.61m |
| Cost of Revenue | CN¥732.33m |
| Gross Profit | -CN¥90.72m |
| Other Expenses | CN¥88.93m |
| Earnings | -CN¥179.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.09 |
| Gross Margin | -14.14% |
| Net Profit Margin | -28.00% |
| Debt/Equity Ratio | 0% |
How did 600568 perform over the long term?
See historical performance and comparison